Morpholino

MO3-mef2d,mef2ca

ID

ZDB-MRPHLNO-070730-5

Name

MO3-mef2d,mef2ca

Previous Names

MO2-mef2d/c
MO3-mef2d+mef2c
MO3-mef2d+mef2ca

Targets

mef2ca (1)
mef2d (1)

Sequence

5' - GAATCTGGATCTTTTTCCTCCCCAT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Perfect match to mef2d sequence, very close to mef2c, predicted to knock down translation of both genes.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO3-mef2d,mef2ca

No data available

Phenotype

Phenotype resulting from MO3-mef2d,mef2ca

No data available

Phenotype of all Fish created by or utilizing MO3-mef2d,mef2ca

Phenotype	Fish	Conditions	Figures
skeletal muscle myosin thick filament assembly disrupted, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. 6 from Hinits et al., 2007
slow muscle cell immature, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. 3 from Hinits et al., 2007
heart rudiment cardiac muscle cell disorganized, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. 5 from Hinits et al., 2012
post-vent region curved ventral, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. 2 from Hinits et al., 2007
heart formation arrested, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. S5 from Hinits et al., 2012
fast muscle cell myofibril composition, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. 2 , Fig. 6 from Hinits et al., 2007
heart rudiment aplastic, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. S5 from Hinits et al., 2012
heart aplastic, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. S5 from Hinits et al., 2012
myofibril assembly disrupted, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. 2 , Fig. 3 from Hinits et al., 2007
slow muscle cell myofibril composition, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. 3 , Fig. 6 from Hinits et al., 2007
cardiac muscle cell undifferentiated, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. S5 from Hinits et al., 2012
cardiac muscle cell differentiation arrested, abnormal	WT + MO3-mef2d,mef2ca	standard conditions	Fig. S5 from Hinits et al., 2012
intersegmental vessel decreased length, abnormal	y1Tg + MO3-mef2d,mef2ca	standard conditions	Fig. S4 from Hinits et al., 2012
intersegmental vessel morphology, abnormal	y1Tg + MO3-mef2d,mef2ca	standard conditions	Fig. S4 from Hinits et al., 2012

Citations